Perspective Therapeutics (CATX) FCF Margin (2010 - 2023)

Perspective Therapeutics has disclosed FCF Margin across 14 years of filings, most recently posting 185.58% for Q4 2023.

• In Q4 2023, FCF Margin changed N/A year-over-year to 185.58%; the TTM figure through Dec 2023 stood at 2648.88% (changed N/A YoY), while the FY2023 annual figure was 2648.88%, changed N/A from the prior year.
• FCF Margin came in at 185.58% for Q4 2023 at Perspective Therapeutics, up from 473.09% in the prior quarter.
• In the past five years, FCF Margin ranged from a high of 185.58% in Q4 2023 to a low of 481.05% in Q1 2023.
• Average FCF Margin over 5 years is 95.31%, with a median of 49.83% recorded in 2022.
• Year-over-year, FCF Margin surged 13302 bps in 2021 and tumbled 43122 bps in 2023.
• Over 5 years, FCF Margin stood at 62.74% in 2019, then jumped by 45 bps to 34.76% in 2020, then soared by 383 bps to 98.26% in 2021, then slumped by 190 bps to 88.32% in 2022, then jumped by 310 bps to 185.58% in 2023.
• Per Business Quant data, the three most recent FCF Margin figures were 185.58% in Q4 2023, 473.09% in Q3 2023, and 413.17% in Q2 2023.